| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 05/06/2005 | WO2005040163A1 Heterocyclic compounds that block the effects of advanced glycation end products (age) |
| 05/06/2005 | WO2005040162A1 5-(2-arylacetamido)isothiazole compounds i |
| 05/06/2005 | WO2005040161A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications |
| 05/06/2005 | WO2005040160A2 Processes for preparation of ziprasidone |
| 05/06/2005 | WO2005040159A1 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer |
| 05/06/2005 | WO2005040158A1 1-′(e)-2-(phenyl) ethenyl-4-(arylalkoxy)-oxazole or - thiazole compounds as her-2 tyrosine kinases inhibitors and their use in the treatment of cancer |
| 05/06/2005 | WO2005040156A1 Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes |
| 05/06/2005 | WO2005040152A1 Heteroyclylphenyl-and heterocyclylpyridyl-substituted azolecarboxamides as herbicides |
| 05/06/2005 | WO2005040144A1 Novel compounds |
| 05/06/2005 | WO2005040136A1 Piperazine derivatives and their use as modulators of nuclear hormone receptor function |
| 05/06/2005 | WO2005040114A1 Compounds having crth2 antagonist activity |
| 05/06/2005 | WO2005040110A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 05/06/2005 | WO2005040109A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 05/06/2005 | WO2005039574A1 Therapeutic agent for keratoconjunctive disorder |
| 05/06/2005 | WO2005039496A2 Inhibitors of cathepsin s |
| 05/06/2005 | WO2005030753A3 Therapeutic agents useful for treating pain |
| 05/06/2005 | WO2005028443A3 Protein tyrosine kinase enzyme inhibitors |
| 05/06/2005 | WO2005021541A3 Process for the production of polymorphs of rosiglitazone maleate |
| 05/06/2005 | WO2005005395A3 Arylamine-substituted quinazolinone compounds |
| 05/06/2005 | WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 05/06/2005 | WO2004082638A3 Histone deacetylase inhibitors |
| 05/06/2005 | WO2004043928A8 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents |
| 05/06/2005 | CA2543805A1 Processes for preparation of ziprasidone |
| 05/06/2005 | CA2543555A1 Therapeutic agent for keratoconjunctival disorder |
| 05/06/2005 | CA2542963A1 Inhibitors of cathepsin s |
| 05/06/2005 | CA2542716A1 Compounds having crth2 antagonist activity |
| 05/06/2005 | CA2542522A1 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer |
| 05/06/2005 | CA2539720A1 1-.prime.(e)-2-(phenyl) ethenyl-4-(arylalkoxy)-oxazole or - thiazole compounds as her-2 tyrosine kinases inhibitors and their use in the treatment of cancer |
| 05/05/2005 | US20050096378 Fundic relaxation; dyspepsia, early satiety, bloating and anorexia; 1-[3-[[(3,4-dihydro-2H-1-benzopyran-2-yl- )methyl]amino]-2-hydroxypropyl]-2,4-imidazolidinedione |
| 05/05/2005 | US20050096364 Iminothiazolidinones as inhibitors of HCV replication |
| 05/05/2005 | US20050096363 Activator of peroxisome proliferator-activated receptor delta |
| 05/05/2005 | US20050096354 Process for the preparation of substituted aryl pyrazoles |
| 05/05/2005 | US20050096348 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile |
| 05/05/2005 | US20050096344 controlling signal transduction; anticancer agents; antitumor agents; angiogenesis inhibitors; atherosclerosis; vision defects; antidiabetic agents; antiinflammatory agents; antiischemic agents |
| 05/05/2005 | US20050096325 use of specified inhibitors of chemokine receptors to treat inflammatory diseases such as asthma, allergic rhinitis, atopic dermatitis, inflammatory bowel diseases, idiopathic pulmonary fibrosis, bullous pemphigoid, allergic colitis, eczema, conjunctivitis, familial eosinophilia |
| 05/05/2005 | US20050096316 Quinoline derivatives(2) |
| 05/05/2005 | US20050096312 Antiserotonine agents; antidepressants; eating disorders; anxiolytic agents; sleep disorders; gastrointestinal disorders; cardiovascular disorders; muscular disorders; endocrine system diseases; muscular disorders; psychological disorders |
| 05/05/2005 | US20050096309 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 05/04/2005 | EP1528061A1 Heterocyclic derivatives which inhibit factor Xa |
| 05/04/2005 | EP1527072A1 Preparation of aztreonam |
| 05/04/2005 | EP1527071A1 Isothiazole derivatives useful as anticancer agents |
| 05/04/2005 | EP1527070A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators |
| 05/04/2005 | EP1527069A2 Pyridines and pyrimidines substituted by 4-trifluoromethylpyrazolyl |
| 05/04/2005 | EP1527062A1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 05/04/2005 | EP1527054A1 Substituted thiazines as material protecting agents |
| 05/04/2005 | EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 05/04/2005 | EP1527050A1 Quinoline derivatives and their use as mycobacterial inhibitors |
| 05/04/2005 | EP1527049A2 Fused heterocyclic compounds as peptidase inhibitors |
| 05/04/2005 | EP1446399B1 Piperazine derivatives having sst1 antagonistic activity |
| 05/04/2005 | EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2005 | EP1240165B1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 05/04/2005 | EP1180519B1 Hydrochloride of fused-heterocycle compound |
| 05/04/2005 | EP1124810B1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/04/2005 | EP0941227B9 Epothilone d, production process, and its use as cytostatic as well as phytosanitary agent |
| 05/04/2005 | EP0886637B9 Inhibitors of microsomal triglyceride transfer protein and method |
| 05/04/2005 | EP0815099B1 Tricyclic amide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 05/04/2005 | CN1612875A 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active |
| 05/04/2005 | CN1612874A Rosiglitazone edisylates and their use as antidiabetics |
| 05/04/2005 | CN1612873A 4-2-n-methyl-n-2-pyridylamidoethoxybenzylthiazolidine-2, 4-dione and pharmaceutical compositions comprising the same |
| 05/04/2005 | CN1612869A Novel 1, 2, 4-thiadiazolium derivatives as melanocortin receptor modulators |
| 05/04/2005 | CN1612865A Triazole derivatives as cyclooxygenase (COX) inhibitors |
| 05/04/2005 | CN1612061A Organophotoreceptor with charge transport material having a hydrazone group linked to an epoxy group and a heterocyclic ring |
| 05/04/2005 | CN1611499A Heterocyclic compounds as inhibitors of rotamase enzymes |
| 05/04/2005 | CN1611489A Intermediates for the synthesis of benzimidazole compounds and process for preparation thereof |
| 05/04/2005 | CN1199954C Benzodiazepine derivatives |
| 05/03/2005 | US6888000 Useful as immune response modifiers due to their ability to induce cytokine biosynthesis and otherwise modulate the immune reponse when administered to animals; viricides, antitumor agents |
| 05/03/2005 | US6887877 Viricide for hepatitis virus |
| 05/03/2005 | US6887874 For producing an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal; therapy of cancer, rheumatoid arthritis |
| 05/03/2005 | US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 05/03/2005 | CA2309558C Substituted oximes as neurokinin antagonists |
| 05/03/2005 | CA2297486C 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor |
| 05/03/2005 | CA2089767C Pyridinyl thiadiazolyl- and oxadiazolyl derivatives |
| 04/28/2005 | WO2005037845A1 Benzothiazole and thiazole[5,5-b] pyridine compositions and their use as ubiquitin ligase inhibitors |
| 04/28/2005 | WO2005037839A1 Norcantharidin derivative compounds, method for the production thereof, compositions containing said compounds and the use thereof |
| 04/28/2005 | WO2005037830A1 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands |
| 04/28/2005 | WO2005037828A1 Novel inhibitors of dpp-iv, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| 04/28/2005 | WO2005037805A2 1,2,4-thiadiazole compounds and pests controlling composition containing the same |
| 04/28/2005 | WO2005037791A1 Compositions and methods for viral inhibition |
| 04/28/2005 | WO2005037781A2 Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 04/28/2005 | WO2005037779A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2005037273A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 04/28/2005 | WO2005037258A2 Cyanoguanidine-based azole compounds useful as malonyl-coa decarboxylase inhibitors |
| 04/28/2005 | WO2005037239A2 Use of a compound from the group of heterodiazoles or a salt of said compound, cosmetic or therapeutic formulation containing said compound or salt, said compound or salt as a therapeutic agent, and said salt |
| 04/28/2005 | WO2005005398A3 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 04/28/2005 | WO2004093817A3 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/28/2005 | WO2004065539A3 Androgen receptor antagonists |
| 04/28/2005 | US20050090546 Compounds such as N,N-dibenzylphenylalanine benzyl ester, used as enzyme inhibitors; prophylaxis of lymphadenopathy associated virus, cancer and malaria |
| 04/28/2005 | US20050090536 Substituted pyrrol-3-ylisoxazoles, e.g., N-benzyl-4-[4-(o-chlorophenyl)-5-isoxazolyl)pyrrole-2-carboxamide; treating diseases that are alleviated by a protein kinase inhibitor, particularly cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 04/28/2005 | US20050090535 Epothilones C, D, E and F, preparation and compositions |
| 04/28/2005 | US20050090534 5-carbonyl or carbamido-4-(4-chlorophenyl)-2-heteroaryl oxazoles; analgesic for diabetic neuropathy |
| 04/28/2005 | US20050090533 Treating schizophrenia by administering an N-(2-aminopyridin-5-yl)amino-phenylisobutyramide, e.g., N-[6-(2-acetylamino-ethylamino)-4-(2-chloro-phenyl)-pyridin-3-yl]-2-(3,5-bis-trifluoromethyl-phenyl)-N-methyl-isobutyramide |
| 04/28/2005 | US20050090532 Medicinal uses of dihydropyrazoles |
| 04/28/2005 | US20050090530 5-(4-(2-(n-methyl-n-(2-pyridyl)amido)ethoxy)benzyl)thiazolidine-2, 4-dione and pharmaceutical compositions comprising the same |
| 04/28/2005 | US20050090524 Novel adamantane derivatives |
| 04/28/2005 | US20050090503 5-HT receptor ligands and uses thereof |
| 04/28/2005 | US20050090502 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents |
| 04/28/2005 | US20050090495 Receptor binding assay using radiolabeled interleukin inhibitors; antiinflammatory agents for eosinophil-dependent inflammatory diseases |
| 04/28/2005 | US20050090490 3-Substituted-4-pyrimidone derivatives |
| 04/28/2005 | US20050090450 enzyme inhibitors such as Pyrazine-2-carboxylic acid (cyclohexyl-{1-[2-(1-cyclopropylaminooxalyl-butylcarbamoyl)-3-isopropyl-pyrrolidine-1-carbonyl]-2,2-dimethyl-propylcarbamoyl}-methyl)-amide, used for treating viral diseases or pretreatment of medical equipment |